NCM
GHDX

Nelson Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Nelson Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-205
Closed -$7K – 312
2014
Q4 		$7K Hold
205
– – ﹤0.01% 253
2014
Q3 		$6K Hold
205
– – ﹤0.01% 273
2014
Q2 		$6K Hold
205
– – ﹤0.01% 270
2014
Q1 		$5K Buy
+205
New +$5.88K ﹤0.01% 238

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Nelson Capital Management's GHDX Position: Q1 2015 in Review

Nelson Capital Management sold out of Genomic Health, Inc. (GHDX) in Q1 2015, closing a stake of 205 shares — an estimated $7K sold.

Nelson Capital Management first reported a position in GHDX in Q1 2014 and held it in 4 quarters. The position peaked at $7K in Q4 2014. 112 funds tracked by Wall St. Rank hold GHDX as of Q1 2015.

  • Nelson Capital Management reported no remaining Genomic Health, Inc. position as of Q1 2015 after selling out during the quarter.
  • Nelson Capital Management sold 205 Genomic Health, Inc. shares in Q1 2015, an estimated $7K.
  • Nelson Capital Management first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 4 quarters.
  • Nelson Capital Management's Genomic Health, Inc. position peaked at $7K in Q4 2014.
  • 112 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2015.

Based on Nelson Capital Management's 13F filing for Q1 2015, filed 12 May 2015.